Gold Standard:Pathological diagnosis and/or clinical diagnosis

4 trials

Sponsors

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, The First Affiliated Hospital of Naval Medical University, Institutes of Biomedical Sciences, Fudan University, Shanghai Changhai Hospital/The First Affiliated Hospital of Naval Medical University

Conditions

Metastatic cancersUrothelial CarcinomaUrothelium carcinomaurothelium carcinoma

Early Phase 1

Clinical trial of DNA methylation detection kit for urothelial carcinoma

RecruitingChiCTR2100046651

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityUrothelial Carcinoma

Start: 2021-03-22Updated: 2022-01-04

A prospective, multicenter, blinded study of urine-based DNA methylation detection in non-invasive diagnosis for urothelial carcinoma

RecruitingChiCTR2100052507

The First Affiliated Hospital of Naval Medical Universityurothelium carcinoma

Start: 2022-02-25Updated: 2023-02-26

Evaluation of the DNA methylation in body fluids as biomarkers for the diagnosis and prognosis of metastases

RecruitingChiCTR2200060532

Institutes of Biomedical Sciences, Fudan UniversityMetastatic cancers

Start: 2022-06-19Updated: 2024-05-21

Unknown Phase

Evaluation of the performance of urine-based DNA methylation assays in urothelial carcinoma: a prospective, multi-center cohort study

RecruitingChiCTR2500101440

Shanghai Changhai Hospital/The First Affiliated Hospital of Naval Medical UniversityUrothelium carcinoma

Start: 2025-05-06Updated: 2026-02-09

Related Papers

<i>PCDHGB7</i> : A universal cancer-only marker (UCOM) and novel diagnostic tool for diverse tumors.

Journal of Clinical Oncology2025-05-28

Hypermethylated TAGMe as a universal-cancer-only methylation marker and its application in diagnosis and recurrence monitoring of urothelial carcinoma.

2024-07-023 citations

Diagnosis of malignant body fluids via cancer-universal methylation in cell-free DNA

JCI Insight2024-04-074 citations